CNX
80
4
MCD
67
2
T
56
2
XRAY
31
-3
JBHT
50
-6
CHK
48
15
R
66
-4
DAL
62
-4
TROW
34
-5
PPL
65
6
HP
41
-4
PPG
61
-5
IBM
81
3
MDT
53
-2
WAT
54
2
PYPL
43
-4
UA
32
8
EBAY
47
-2
NEM
48
2
UNP
40
-2
CNX
80
4
MCD
67
2
T
56
2
XRAY
31
-3
JBHT
50
-6
CHK
48
15
R
66
-4
DAL
62
-4
TROW
34
-5
PPL
65
6
HP
41
-4
PPG
61
-5
IBM
81
3
MDT
53
-2
WAT
54
2
PYPL
43
-4
UA
32
8
EBAY
47
-2
NEM
48
2
UNP
40
-2
Financhill
Back

Coca-Cola Europacific Partners PLC Vs. Apellis Pharmaceuticals Industry Stock Comparison

Buy
51

CCEP
Coca-Cola Europacific Partners PLC

Last Price:
81.09
Seasonality Move:
1.14%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Buy
51
Coca-Cola Europacific Partners PLC (CCEP) is a Buy

Is Coca-Cola Europacific Partners PLC a Buy, Sell or Hold?

  • The current Coca-Cola Europacific Partners PLC [CCEP] share price is $81.09. The Score for CCEP is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
  • CCEP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

CCEP Stock Price Chart

What is Coca-Cola Europacific Partners PLC's stock price today?

  • The Coca-Cola Europacific Partners PLC share price today is $81.09
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CCEP is experiencing buying pressure, which is a positive indicator for future bullish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

CCEP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.2 Buy
Relative Strength Index (14 RSI): 60.96 Buy
Chaikin Money Flow: 937592 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (78.44 - 81.44) Buy
Bollinger Bands (100): (72.27 - 78.19) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

CCEP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 80.97 Buy
20-day SMA: 80.57 Buy
50-day SMA: 76.89 Buy
200-day SMA: 71.62 Buy
8-day EMA: 80.99 Buy
20-day EMA: 80.1 Buy
50-day EMA: 77.83 Buy
200-day EMA: 72.07 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

Coca-Cola Europacific Partners PLC Earnings Growth & CCEP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.35 per share, and an increase next year of $0.38 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

Coca-Cola Europacific Partners PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):